White Papers/Articles
FDA-approved Drugs of Interest to Underwriters: Recent and Relevant Therapeutics --- white-papers
December 15, 2023
White Papers/Articles
ACA Risk Adjustment Leaders: You’re Leaving Big Money on the Table --- white-papers
March 15, 2024
White Papers/Articles
Time on Your Side: Five Scrappy Ways Your PEO Can Use AI to Shrink the Group Health Sales Cycle --- white-papers
September 1, 2023
White Papers/Articles
Three Reasons Your PEO Should Use a Predictive Model for Group Health Underwriting --- white-papers
April 1, 2023
White Papers/Articles
Everyone into the (Data) Pool --- white-papers
January 4, 2024
White Papers/Articles
Irix® Risk Score Stratifies Mortality Risk with the Addition of Credit Data --- white-papers
December 15, 2023
White Papers/Articles
RGA’s Actuarial Validation of Milliman Irix® Risk Score 3.0 with Credit --- white-papers
December 12, 2023
White Papers/Articles
Post-acute COVID-19 Mortality and Morbidity Effects --- white-papers
October 13, 2023
White Papers/Articles
Cutting the Bluster on AI in Group Health Underwriting --- white-papers
July 7, 2023
White Papers/Articles
Consumer Data and Its Applications in Health Insurance Underwriting --- white-papers
May 31, 2023
White Papers/Articles
Irix® Risk Score with Medical Data: Stratifying Mortality Risk by Combining Prescription Drug History and Medical Claims Records --- white-papers
January 23, 2023
White Papers/Articles
Collaborative Study: The Protective Value of Medical Data --- white-papers
January 20, 2023
White Papers/Articles
RGA’s Actuarial Validation of Irix® Risk Score 3.0 --- white-papers
January 6, 2023
White Papers/Articles
Five Ways a Morbidity Predictive Model Can Relieve Medicare Supplement Market Pressures --- white-papers
January 26, 2022
